You are here

Article Text

Article menu

This article has a correction. Please see:

Letters to the editor
Role of cisapride in preterm infants
  1. J S CRAIG,
  2. B G MCCLURE
  1. Department of Child Health
  2. The Queen’s University of Belfast
  3. Institute of Clinical Science
  4. Belfast BT12 6BJ
  5. Royal Maternity Hospital
  6. Belfast BT12 6BB
    1. T R J TUBMAN
    1. Department of Child Health
    2. The Queen’s University of Belfast
    3. Institute of Clinical Science
    4. Belfast BT12 6BJ
    5. Royal Maternity Hospital
    6. Belfast BT12 6BB

      https://doi.org/10.1136/fn.80.3.F252d

      Statistics from Altmetric.com

        Request Permissions

        If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

        Editor—Enriquez et alprovided evidence that cisapride given to preterm infants was beneficial and free of side effects.1 A study of similar design, based in our unit, was halted by the Medicines Control Agency (MCA) because of the possible risks of prolonged QT intervals.2 It is therefore interesting to note …

        View Full Text